New diabetes clinical trial: Efficacy and Safety of Efpeglenatide Versus Placebo in Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Metformin Alone or in Combination With Sulfonylurea

Published on: December 10, 2018 at 10:30PM
Condition:   Type 2 Diabetes Mellitus
Interventions:   Drug: Efpeglenatide SAR439977;   Drug: Placebo;   Drug: Metformin;   Drug: Sulfonylurea
Sponsor:   Sanofi
Not yet recruiting
https://ift.tt/2Sy4I7G